Din, Mary Glaiza Mikaela B.
HRN: 04-19-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
CEFUROXIME 1.5GM (VIAL)
06/11/2023
06/18/2023
IV
1.2gm
Q8
UTI
Waiting Final Action